Efficacy of Sitagliptine on Bone and Mineral Metabolism:S-BMM study
Not Applicable
- Conditions
- Type2 diabetes mellitus
- Registration Number
- JPRN-UMIN000019867
- Lead Sponsor
- niversity of Occupational and Environmental Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of ketoacidosis, patients with type 1 diabetes, patients with nephropathy (serum creatinine: males >1.5 mg/dL females >1.3 mg/dL), patients treated with insulin, and women who were possibly pregnant were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome was changes in BAP at 6 months.
- Secondary Outcome Measures
Name Time Method